feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs",https://benzinga.com/general/biotech/21/09/22947673/the-daily-biotech-pulse-lilly-regeneron-ink-covid-19-drug-deal-with-us-regulatory-setback-for-cal,https://j.mp/3lsSdKY
